ID | 1391 | |
PMID | 20089796 | |
Year | 2010 | |
Sequence | APQIPPNWHIPSIQDA ATPYHPPATPNNMGL | |
Name | HSV-1 gD 287-317 (group-2) | |
Length | 31 | |
N-Terminal Modification | Free | |
C-Terminal Modification | Free | |
Linear/ Cyclic | Linear | |
Chirality | L | |
Chemical Modification | None | |
Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
Nature of Peptide/Cargo | Intranasal immunizations with group 2 peptides induced strong CD4+ T cell proliferation in the conjunctiva. | |
Mechanism | Not mentioned | |
Cargo Sequence/Structure | None | |
Name of cargo | Not applicable | |
Assay | FACS | |
Enhancer | CpG adjuvant | |
Properties of enhancer | Not mentioned | |
Concentration | 50 µl per nasal cavity | |
Incubation time | Immunized on 0,14 and 21 days. Euthanized after 10 days. | |
Tissue permeability (value with units) | Detectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels | |
Tissue Sample | Nasal cavity of New Zealand White rabbits | |
Ex vivo/In vivo/In vitro | in vivo | |
STRUCTURE |
| |
SMILES | N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N2[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]5[C@H](OCCC5) N[C@H](C(=O)N[C@H](C(=O)N5[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C=O) CC(C)C)CCSC)CC(=O)N)CC(=O)N)CCC5)[C@H] (O)C)C)CCC)Cc5[nH]cnc5)Cc5ccc(cc5)O) CCC)[C@H](O)C)C)C)CC(=O)O)CCC(=O)N) [C@H](CC)C)CO)CCC4)[C@H](CC)C)Cc4[nH]cnc4)Cc4c [nH]c5c4cccc5)CC(=O)N)CCC3)CCC2) [C@H](CC)C)CCC(=O)N)CCC1)C |